238 related articles for article (PubMed ID: 34086694)
21. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
[TBL] [Abstract][Full Text] [Related]
22. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
[TBL] [Abstract][Full Text] [Related]
23. LDL-cholesterol goal achievement, cardiovascular disease, and attributed risk of Lp(a) in a large cohort of predominantly genetically verified familial hypercholesterolemia.
Bogsrud MP; Græsdal A; Johansen D; Langslet G; Hovland A; Arnesen KE; Mundal LJ; Retterstøl K; Wium C; Holven KB
J Clin Lipidol; 2019; 13(2):279-286. PubMed ID: 30910667
[TBL] [Abstract][Full Text] [Related]
24. Familial Hypercholesterolemia Among Young Adults With Acute Coronary Syndrome.
Haskiah F; Erez D; Khaskia A
Am J Cardiol; 2023 Jan; 186():189-195. PubMed ID: 36270825
[TBL] [Abstract][Full Text] [Related]
25. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
Schmidt N; Dressel A; Grammer TB; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Koenig W; Otte B; Parhofer KG; Reinhard W; Schatz U; Schunkert H; Steinhagen-Thiessen E; Vogt A; Laufs U; März W
Atherosclerosis; 2018 Oct; 277():314-322. PubMed ID: 30270065
[TBL] [Abstract][Full Text] [Related]
26. Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up.
Auckle R; Su B; Li H; Xu S; Xie M; Song Y; Abdul Quddus M; Xu Y; Liu B; Che W
PLoS One; 2017; 12(10):e0186815. PubMed ID: 29088271
[TBL] [Abstract][Full Text] [Related]
27. The First Report of a Real-world Experience With a PCSK9 Inhibitor in a Large Familial Hyperlipidemia and Very-high-risk Middle Eastern Population.
Iqbal S; Sabbour HM; Siddiqui MS; Tikriti AA; Santos RD; Buckley A
Clin Ther; 2022 Oct; 44(10):1297-1309. PubMed ID: 36127165
[TBL] [Abstract][Full Text] [Related]
28. Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience.
Mandraffino G; Scicali R; Rodríguez-Carrio J; Savarino F; Mamone F; Scuruchi M; Cinquegrani M; Imbalzano E; Di Pino A; Piro S; Rabuazzo AM; Squadrito G; Purrello F; Saitta A
J Clin Lipidol; 2020; 14(2):231-240. PubMed ID: 32111581
[TBL] [Abstract][Full Text] [Related]
29. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C.
van Delden XM; Huijgen R; Wolmarans KH; Brice BC; Barron JK; Blom DJ; Marais AD
Atherosclerosis; 2018 Oct; 277():327-333. PubMed ID: 30270067
[TBL] [Abstract][Full Text] [Related]
30. Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis.
Matta A; Bongard V; Bouisset F; Taraszkiewicz D; Rabès JP; Ferrières J
Med Sci Monit; 2021 May; 27():e928784. PubMed ID: 33958572
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
Nanchen D; Gencer B; Auer R; Räber L; Stefanini GG; Klingenberg R; Schmied CM; Cornuz J; Muller O; Vogt P; Jüni P; Matter CM; Windecker S; Lüscher TF; Mach F; Rodondi N
Eur Heart J; 2015 Sep; 36(36):2438-45. PubMed ID: 26142466
[TBL] [Abstract][Full Text] [Related]
32. Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management.
Miname MH; Santos RD
Prog Cardiovasc Dis; 2019; 62(5):414-422. PubMed ID: 31669498
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database.
Sonmez A; Demirci I; Haymana C; Tasci I; Ayvalı MO; Ata N; Ezgu FS; Bayram F; Barcin C; Caglayan M; Ülgü MM; Birinci S; Tokgozoglu L; Satman I; Kayikcioglu M
Atherosclerosis; 2023 Jun; 375():9-20. PubMed ID: 37216728
[TBL] [Abstract][Full Text] [Related]
34. The prevalence and management of familial hypercholesterolemia in patients with acute coronary syndrome in the Polish tertiary centre: Results from the TERCET registry with 19,781 individuals.
Dyrbuś K; Gąsior M; Desperak P; Osadnik T; Nowak J; Banach M
Atherosclerosis; 2019 Sep; 288():33-41. PubMed ID: 31319356
[TBL] [Abstract][Full Text] [Related]
35. The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia.
Lalić K; Rajković N; Popović L; Lukač SS; Stošić L; Rasulić I; Lalić NM
Atherosclerosis; 2018 Oct; 277():298-303. PubMed ID: 30270062
[TBL] [Abstract][Full Text] [Related]
36. What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Kayikcioglu M; Tokgozoglu L; Dogan V; Ceyhan C; Tuncez A; Kutlu M; Onrat E; Alici G; Akbulut M; Celik A; Yesilbursa D; Sahin T; Sonmez A; Ozdogan O; Temizhan A; Kilic S; Bayram F; Sabuncu T; Coskun FY; Ildizli M; Durakoglugil E; Kirilmaz B; Yilmaz MB; Yigit Z; Yildirim AB; Gedikli O; Topcu S; Oğuz A; Demir M; Yenerçağ M; Yıldırır A; Demircan S; Yilmaz M; Kaynar LG; Aktan M; Durmus RB; Gokce C; Ozcebe Oİ; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O; Can LH
Atherosclerosis; 2018 Oct; 277():341-346. PubMed ID: 30270069
[TBL] [Abstract][Full Text] [Related]
37. Gaps in the Care of Subjects with Familial Hypercholesterolemia: Insights from the Thai Familial Hypercholesterolemia Registry.
Ganokroj P; Muanpetch S; Deerochanawong C; Phimphilai M; Leelawattana R; Thongtang N; Krittayaphong R; Anthanont P; Vathesatogkit P; Sriphrapradang C; Senthong V; Torpongpun A; Suteerayongprasert P; Pengpong N; Sathavarodom N; Sunanta U; Porntharukchareon T; Kiatpanabhikul P; Kaewkrasaesin C; Suraamornkul S; Kongkit J; Umphonsathien M; Chattranukulchai P; Jiamjarasrungsi W; Khovidhunkit W
J Atheroscler Thromb; 2023 Dec; 30(12):1803-1816. PubMed ID: 37197952
[TBL] [Abstract][Full Text] [Related]
38. Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography.
Li JJ; Li S; Zhu CG; Wu NQ; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Jiang ZW; Sun J; Liu G; Dong Q
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):570-579. PubMed ID: 27932355
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: Results of the EXPLORE-J study.
Harada-Shiba M; Ako J; Arai H; Hirayama A; Murakami Y; Nohara A; Ozaki A; Uno K; Nakamura M
Atherosclerosis; 2018 Oct; 277():362-368. PubMed ID: 30270072
[TBL] [Abstract][Full Text] [Related]
40. The Gulf Survey on Anemia Management (GSAM 2005).
Alsuwaida A; Abdulkareem A; Alwakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):206-14. PubMed ID: 17496396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
